Dr. Hamilton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
23 Pocono Rd
Denville, NJ 07834Phone+1 646-227-3813Fax+1 908-542-3220
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1991 - 1994
- Brigham and Women's HospitalResidency, Internal Medicine, 1983 - 1986
- Harvard Medical SchoolClass of 1983
Certifications & Licensure
- NJ State Medical License 1996 - 2025
- NY State Medical License 1985 - 2024
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2014
- Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
- Top Doctors: New York Metro Area Castle Connolly, 2005, 2009-2014
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsTP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, Alison J Moskowitz, Robert N Stuver
Blood Advances. 2023-09-12 - 70 citationsActivity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.Robert Stuver, Gunjan L Shah, Neha S Korde, Lindsey E Roeker, Anthony R Mato
Cancer Cell. 2022-06-13 - 2 citationsClinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.Fushen Sha, Michelle Okwali, Anna Alperovich, Philip C Caron, Lorenzo Falchi
Blood Cancer Journal. 2022-02-10
Abstracts/Posters
- High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...Audrey Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin LymphomaAudrey Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin LymphomaAudrey Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: